Isodiur Hta

Torasemide, the active ingredient in Isodiur Hta, is a loop diuretic presented as an oral tablet for oral use. It promotes the excretion of excess sodium and water, thereby reducing fluid accumulation in patients with heart‑failure‑related edema, hepatic or renal disease‑associated swelling, and contributes to blood‑pressure control in hypertension.

GNH USA supplies Isodiur Hta as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide under stringent quality assurance and regulatory standards.

Torasemide is a loop diuretic used to manage conditions characterized by fluid retention.

- Heart‑failure‑related edema: reduces fluid overload and improves symptoms. - Hepatic or renal disease‑associated edema: facilitates removal of excess fluid. - Hypertension: assists in lowering elevated blood pressure.

Torasemide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Increased urination: frequent need to void. - Electrolyte imbalance: low potassium or sodium levels. - Dizziness or light‑headedness: especially on standing. - Headache: mild to moderate intensity.

Serious or Rare Side Effects: - Severe dehydration: marked fluid loss leading to hypotension. - Acute kidney injury: sudden decline in renal function.

When prescribing torasemide, clinicians should consider several safety measures to minimize risk.

- Monitor electrolytes: check serum potassium and sodium regularly. - Assess renal function: evaluate creatinine and eGFR before and during therapy. - Adjust dose in the elderly: start with the lowest effective dose. - Caution in patients with gout: diuretic may raise uric acid levels. - Avoid concurrent use with other potent diuretics unless necessary. - Store at room temperature: keep in original packaging, protect from moisture and light.

Torasemide can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - NSAIDs (e.g., ibuprofen): may reduce diuretic effect. - ACE inhibitors or ARBs: increased risk of renal impairment and hyperkalemia. - Lithium: enhanced lithium toxicity due to reduced clearance.

Moderate Interactions (Monitor Closely): - Antihypertensives (e.g., beta‑blockers): additive blood‑pressure lowering. - Digoxin: risk of digoxin toxicity from electrolyte shifts. - Corticosteroids: may potentiate fluid loss and electrolyte disturbances.